Literature DB >> 7913535

Treatment of patients with intracranial arterial aneurysms in the haemorrhagic period.

Y N Zubkov1.   

Abstract

Our research protocol was implemented in the treatment of 395 patients in the acute period following aneurysmal subarachnoid haemorrhage. Patients are classified as follows: Compensated (roughly Hunt and Hess I-II); Subcompensated (Hunt and Hess III); and Decompensated (Hunt and Hess IV-V). Only patients in the compensated state are deemed candidates for acute surgery. Patients presenting in the subcompensated or decompensated state undergo aggressive supportive treatment. Vasospasm is treated with balloon angioplasty as soon as the diagnosis is made; early interdiction of this process lowers the risk of neurologic deficit. A complex regimen of antifibrinolytic therapy is instituted; rebleeding rates have been reduced by 50% using a combination of heparin and aminocaproic acid. Ventriculostomy is performed in all decompensated patients. All intracranial haematomas with evidence of mass effect are immediately evacuated. Patients undergo craniotomy for aneurysm when their condition stabilizes in compensated state.

Entities:  

Mesh:

Year:  1994        PMID: 7913535     DOI: 10.1080/01616412.1994.11740181

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  Timing of operation for poor-grade aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

Authors:  Qiao Zhang; Lu Ma; Yi Liu; Min He; Hong Sun; Xiang Wang; Yuan Fang; Xu-hui Hui; Chao You
Journal:  BMC Neurol       Date:  2013-08-19       Impact factor: 2.474

2.  Ultra-early endovascular treatment improves prognosis in High grade aneurysmal subarachnoid hemorrhage: A single-center retrospective study.

Authors:  Botao Wu; Zhe Huang; Huan Liu; Jiayao He; Yan Ju; Ziwei Chen; Taiwei Zhang; Fuxin Yi
Journal:  Front Neurol       Date:  2022-08-12       Impact factor: 4.086

3.  Acute management of poor condition subarachnoid hemorrhage patients.

Authors:  Archavlis Eleftherios; Mario Nazareno Carvi y Nievas
Journal:  Vasc Health Risk Manag       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.